(S)-(+)-2,2-Dimethylcyclopropane Carboxamide (CAS 75885-58-4) is a compound of significant importance within the pharmaceutical industry, primarily serving as a critical intermediate in the synthesis of Cilastatin. Cilastatin, in turn, is a vital component that works synergistically with antibiotics like Imipenem. Its function is to inhibit the enzymatic degradation of Imipenem in the kidneys, thereby extending its therapeutic lifespan and increasing its effectiveness against a broad spectrum of bacterial infections. For R&D scientists and product formulators, understanding the properties and sourcing options for this intermediate is crucial for developing advanced antibacterial treatments.

The chemical structure and high chiral purity of (S)-(+)-2,2-Dimethylcyclopropane Carboxamide contribute directly to the efficacy and safety of the final Cilastatin product. Possessing an assay of ≥99.0% and a chiral content also exceeding 99.0%, this compound ensures that the synthesized drug is enantiomerically pure, minimizing potential side effects and maximizing therapeutic benefit. Its physical characteristics, such as being a white crystal powder, and stable properties like a melting point of 135-137°C, make it amenable to standard pharmaceutical manufacturing processes. When seeking to buy (S)-(+)-2,2-Dimethylcyclopropane Carboxamide, it is essential to partner with a reliable CAS 75885-58-4 supplier that guarantees these stringent specifications.

Manufacturers like NINGBO INNO PHARMCHEM CO.,LTD. play a pivotal role in the pharmaceutical supply chain by offering this high-quality intermediate. They provide an accessible avenue for companies to procure this vital component, ensuring a consistent supply for ongoing research and large-scale production. Exploring options to secure a competitive Cilastatin intermediate price often leads back to well-established Chinese manufacturers who can deliver both quality and cost-efficiency. This allows pharmaceutical companies to optimize their production costs without compromising on the integrity of their active pharmaceutical ingredients (APIs).

The demand for effective antibacterial agents is ever-increasing, driven by the rise of antibiotic-resistant bacteria. Therefore, the reliable availability of intermediates like (S)-(+)-2,2-Dimethylcyclopropane Carboxamide is more critical than ever. By collaborating with trusted suppliers, pharmaceutical innovators can accelerate their drug development pipelines and bring much-needed therapies to market. We invite you to connect with us to inquire about the purchase of (S)-(+)-2,2-Dimethylcyclopropane Carboxamide and discover how our commitment to quality and service can support your project.